{"title":"Dual-payload ADCs move into first oncology clinical trials","authors":"","doi":"10.1038/d41573-025-00121-y","DOIUrl":null,"url":null,"abstract":"Two dual-payload antibody–drug conjugates are now in the clinic for cancer, with many more on the way.","PeriodicalId":18847,"journal":{"name":"Nature Reviews Drug Discovery","volume":"27 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews Drug Discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/d41573-025-00121-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Two dual-payload antibody–drug conjugates are now in the clinic for cancer, with many more on the way.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
